Attention Shareholders: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ADC Therapeutics SA (ADCT)
Investigation into ADC Therapeutics SA September 27, 2022 New York, NY Attention all investors! Pomerantz LLP is currently looking into claims regarding ADC Therapeutics SA (“ADC” or the “Company”). If you are a shareholder of ADC (NYSE: ADCT), please reach out to Robert S. Willoughby at [email protected] or call 888-476-6529, ext. 7980. The investigation is…